MMP1 and non-small cell lung carcinoma: The authors found that MMP-1, MMP-7 and MMP-9 serum levels were slightly elevated in NSCLC patients, prompting the team to rely on larger cohorts for the evaluation of these MMPs as biomarkers for NSCLC.